The Medical Devices and Blood Safety and Quality (Fees Amendment) Regulations 2023
Typestatutory instrumentDate27 Mar 2023Articles25Cited by5 documents
- 3Amendment of the Medical Devices Regulations 2002
- 4Amendment of regulation 2 in relation to England, Scotland and Wales (interpretation)
- 5Amendment of regulation 16 in relation to England, Scotland and Wales (procedures for general medical device
- 6Amendment of regulation 29 in relation to England, Scotland and Wales (procedures for active implantable med
- 7Amendment of regulation 52 (interpretation of Part VI)
- 8Amendment of regulation 53 in relation to England, Scotland and Wales (fees in connection with the registrat
- 9Amendment of regulation 53 in relation to Northern Ireland (fees in connection with the registration of devi
- 10Amendment of regulation 54 in relation to England, Scotland and Wales (fees payable in connection with the
- 11Amendment of regulation 55 in relation to England, Scotland and Wales (fees payable in connection with the
- 12Amendment of regulation 55 in relation to Northern Ireland (fees payable in connection with the designation
- 13Amendment of regulation 56 in relation to England, Scotland and Wales (fees payable in relation to clinical
- 14New regulation 56B
- 15New regulation 56C
- 16New regulation 56D
- 18Amendment of the Medical Devices (Northern Ireland Protocol) Regulations 2021
- 19Amendment of regulation 7 (registration of custom-made devices)
- 20Amendment of regulation 16 (clinical investigation fees)
- 21New regulation 17A (advice in relation to intended clinical investigations)
- 22Amendment of regulation 19 (fees payable in connection with the designation of notified bodies)
- 23New Part 4A
- 24Amendment of Schedule 1 (fees for clinical investigations)
- 25Amendment of Schedule 2 (fees in connection with the designation of notified bodies)
Source: legislation.gov.uk (The National Archives), UK legislation with its point-in-time versions. Official publication. Reuse: Open Government Licence v3.0.